Diabetes Complications at Presentation and One Year by Glycated Haemoglobin at Diagnosis in a Multiethnic and Diverse Socioeconomic Population: Results from the South London Diabetes Study

Table 3

Prospective comparisons between participants diagnosed with HbA_1c < 48 mmol/mol and those diagnosed with HbA_1c ≥ 48 mmol/mol at year 1.

	with data	HbA1c < 48 mmol/mol (6.5%)	HbA1c ≥ 48 mmol/mol (6.5%)	value
Median (IQR) HbA1c at year 1
HbA1c (mmol/mol)	1251	43.17 (40.98–47.54),	49.72 (45.35–57.37)	<0.0001
HbA1c (%)		6.10 (5.90–6.50)	6.70 (6.30–7.40),
New complication status at year 1
Retinopathy (%)	1220	32 (10.88)	126 (13.61)	0.2257
Microalbuminuria (%)	1025	22 (9.21)	123 (15.65)	0.0123
MI (%)	1278	10 (3.38)	12 (1.22)	0.0124
Stroke (%)	1272	4 (1.4)	7 (0.72)	0.2951
Cumulative microalbuminuria and MI status at year 1
Microalbuminuria (%)	1218	39 (14.77)	191 (20.02)	0.0540
MI (%)	1487	29 (8.55)	59 (5.14)	0.0190
Medication status at year 1
Receiving oral agents (%)	1296	92 (30.6)	715 (71.9)	<0.0001
Receiving insulin (%)	1294	8 (2.67)	37 (3.72)	0.3817
Cardiovascular risk factor status (SD) at year 1
BMI (kg/m^2)	1308	31.28 (±6.44)	32.14 (±6.35)	0.0400
BPD (mmHg)	1282	80.21 (±10.76)	82.22 (±10.91)	0.0057
BPS (mmHg)	1284	135.42 (±18.28)	134.57 (±17.23)	0.4614
LDL-C (mmol/L)	1164	2.49 (±0.80)	2.51 (±0.84)	0.7485
HDL-C (mmol/L)	1200	1.32 (±0.48)	1.25 (±0.34)	0.0081
Total cholesterol (mmol/L)	1234	4.40 (±1.30)	4.40 (±1.20)	0.0942
Triglycerides (mmol/L)	1164	2.49 (±0.80)	2.51 (±0.84)	0.5454
Smoking status (%)	1149	190 (21.62)	41 (15.19)	0.0211